CHL1 and pituitary tumor: In pituitary tumors, membrane-anchored wt-FGFR4 (wild-type FGFR4) formed a complex with neural cell adhesion molecule (NCAM) and N-cadherin, imparting sensitivity to FGFR inhibitor treatment.